These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. D-myeloma. Report of two cases. Zawadzki ZA; Rubini JR Arch Intern Med; 1967 Apr; 119(4):387-93. PubMed ID: 4164512 [No Abstract] [Full Text] [Related]
23. [2 new cases of initial or secondarily non-excreting plasma cell myelomas]. Prost A; Soulilou JP; Gardais J; Hurez D; Cottin S Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):151-7. PubMed ID: 4574504 [No Abstract] [Full Text] [Related]
24. Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance. Br J Haematol; 1973 Jan; 24(1):123-39. PubMed ID: 4805842 [No Abstract] [Full Text] [Related]
25. Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma. Report on 10 patients and a review of the literature. Pruzanski W; Watt JG Ann Intern Med; 1972 Dec; 77(6):853-60. PubMed ID: 4644164 [No Abstract] [Full Text] [Related]
26. Study of the frequency of kappa and lambda light chains in 347 sera containing a monoclonal IgG, IgA, IgD, or Bence-Jones protein. Fine JM Rev Eur Etud Clin Biol; 1970 Feb; 15(2):199-202. PubMed ID: 4192027 [No Abstract] [Full Text] [Related]
27. IgD multiple myeloma: a report of five cases. Fishkin BG; Glassy FJ; Hattersley PG; Hirose FM; Spiegelberg HL Am J Clin Pathol; 1970 Feb; 53(2):209-14. PubMed ID: 5415911 [No Abstract] [Full Text] [Related]
28. Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide. Bergsagel DE; Cowan DH; Hasselback R Can Med Assoc J; 1972 Nov; 107(9):851-5. PubMed ID: 4653931 [TBL] [Abstract][Full Text] [Related]
29. [A case of D-myeloma]. Ota G; Oe K; Tanishima K; Onchi K Nihon Ketsueki Gakkai Zasshi; 1968 Jun; 31(3):318-24. PubMed ID: 4180034 [No Abstract] [Full Text] [Related]
30. The antigenic pattern of immunoglobulins. Ouchterlony O G Mal Infett Parassit; 1966 Dec; 18(12):Suppl:942-8. PubMed ID: 4173174 [No Abstract] [Full Text] [Related]
31. IgD-myelomatosis. Report of a case. Dammacco F; Bonomo L Scand J Haematol; 1968; 5(3):161-70. PubMed ID: 4179184 [No Abstract] [Full Text] [Related]
32. [IgD myeloma--clinical study of 6 cases and review of cases reported in Japan]. Onodera S; Shibata A; Tachibana Y; Miura A; Suzuki A Saishin Igaku; 1970 Feb; 25(2):403-13. PubMed ID: 4192272 [No Abstract] [Full Text] [Related]
33. Antigenic relationships of Bence Jones proteins, myeloma globulins, and normal human gama-globulin. MIGITA S; PUTNAM FW J Exp Med; 1963 Jan; 117(1):81-104. PubMed ID: 13935673 [TBL] [Abstract][Full Text] [Related]
34. [Clinical importance of paraprotein of the type kappa and lambda in Bence-Jones myeloma]. Iavorskiĭ LI; Andreeva NE; Antipova LG; Riauzova LN Probl Gematol Pereliv Krovi; 1979 Jun; 24(6):3-9. PubMed ID: 111238 [No Abstract] [Full Text] [Related]
39. Significance of M-components in plasma cell myeloma and related disorders. Kano T Tohoku J Exp Med; 1970 Dec; 102(4):341-67. PubMed ID: 4101555 [No Abstract] [Full Text] [Related]
40. [ON A CASE OF MICROMOLECULAR MYELOMA WITH DEMONSTRATION OF IMMUNOCHEMICAL IDENTITY BETWEEN THE SERUM MICROMOLECULE AND THE URINARY BENCE-JONES PROTEIN]. BERROD J; LARRAT J; SANDOR G; SUREAU B Ann Biol Clin (Paris); 1964; 22():533-41. PubMed ID: 14184012 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]